Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21169060 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: cetuximab + cisplatin + vinorelbine;   Drug: cisplatin + vinorelbine

Study has passed its completion date and status has not been verified in more than two years.